The recently published technology assessment of continuous positive airway pressure
(CPAP), prepared by the Agency for Healthcare Research and Quality (AHRQ) and entitled …

Whether or not there are cardiovascular benefits of using continuous positive airway
pressure (CPAP) for patients with obstructive sleep apnea (OSA) is a foundational question …

Continuous positive airway pressure (CPAP) is the first-line treatment for obstructive sleep
apnea (OSA). Although CPAP improves symptoms (eg, daytime sleepiness), there is a lack …

Abstract Study Objectives Randomized controlled trials (RCTs) have shown no reduction in
adverse cardiovascular (CV) events in patients randomized to continuous positive airway …

Clinical trials are defined as experiments in humans designed to evaluate the effects of
specific treatments, or exposure condition that by design reduce random error and bias. 1 …

Despite considerable advances in the relatively young field of sleep research, the
importance of obstructive sleep apnea (OSA) remains underappreciated. A vast body of …

Obstructive sleep apnea (OSA) is associated with major adverse cerebrovascular and
cardiovascular events (MACCEs)(1). Multiple studies have demonstrated the beneficial …

Extract The recently published technology assessment of continuous positive airway
pressure (CPAP), prepared for the Agency for Healthcare Research and Quality (AHRQ) of …

Obstructive sleep apnea is a common disorder that has been associated with an increased
risk of cardiovascular disease. 1 Continuous positive airway pressure (CPAP) is frequently …

In their recent provocative commentary, Pack et al.[1] contend that the neutral results of
randomized controlled trials (RCTs) of continuous positive airways pressure (CPAP) for …